Director & Chief Medical Officer
Director & Chief Medical Officer at RenovoRx, Inc., filing insider transactions between 2025-06-05 and 2026-01-21.
| SEC ↗ |
| 2025-12-16 | RNXT | Purchase | 12.0K | $0.85 | $10K | SEC ↗ |
| 2025-12-05 | RNXT | Purchase | 10.0K | $0.96 | $10K | SEC ↗ |
| 2025-11-24 | RNXT | Purchase | 12.0K | $0.80 | $10K | SEC ↗ |
| 2025-11-21 | RNXT | Purchase | 10.0K | $0.80 | $8K | SEC ↗ |
| 2025-06-05 | RNXT | Purchase | 21.0K | $1.40 | $29K | SEC ↗ |